BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2120331)

  • 1. Gene deletions force nonsecretory alpha-chain disease plasma cells to produce membrane-form alpha-chain only.
    Cogné M; Preud'homme JL
    J Immunol; 1990 Oct; 145(8):2455-8. PubMed ID: 2120331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic alterations in a case of alpha heavy chain disease leading to the generation of composite exons from the JH region.
    Bentaboulet M; Mihaesco E; Gendron MC; Brouet JC; Tsapis A
    Eur J Immunol; 1989 Nov; 19(11):2093-8. PubMed ID: 2513209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The productive gene for alpha-H chain disease protein MAL is highly modified by insertion-deletion processes.
    Tsapis A; Bentaboulet M; Pellet P; Mihaesco E; Thierry D; Seligmann M; Brouet JC
    J Immunol; 1989 Dec; 143(11):3821-7. PubMed ID: 2555418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha heavy chain disease alpha mRNA contain nucleotide sequences of unknown origins.
    Fakhfakh F; Dellagi K; Ayadi H; Bouguerra A; Fourati R; Ben Ayed F; Brouet JC; Tsapis A
    Eur J Immunol; 1992 Nov; 22(11):3037-40. PubMed ID: 1425927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha heavy chain disease of patient MAL: structure of the non-functional rearranged alpha gene translocated on chromosome 9.
    Pellet P; Tsapis A; Brouet JC
    Eur J Immunol; 1990 Dec; 20(12):2731-5. PubMed ID: 2125275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exon skipping without splice site mutation accounting for abnormal immunoglobulin chains in nonsecretory human myeloma.
    Cogné M; Guglielmi P
    Eur J Immunol; 1993 Jun; 23(6):1289-93. PubMed ID: 8500524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
    Zhang DL; Ji L; Li YD
    Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternate splice sites within the human VH gene coding sequences lead to truncated Ig mu-chains.
    Mounir S; Guglielmi P; Preud'homme J; Nau F; Cogné M
    J Immunol; 1990 Jan; 144(1):342-7. PubMed ID: 2104890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple genomic defects result in an alternative RNA splice creating a human gamma H chain disease protein.
    Guglielmi P; Bakhshi A; Cogne M; Seligmann M; Korsmeyer SJ
    J Immunol; 1988 Sep; 141(5):1762-8. PubMed ID: 3137265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsecretory alpha-chain disease with immunoproliferative small-intestinal disease.
    Matuchansky C; Cogné M; Lemaire M; Babin P; Touhard G; Chamaret S; Preud'homme JL
    N Engl J Med; 1989 Jun; 320(23):1534-9. PubMed ID: 2498659
    [No Abstract]   [Full Text] [Related]  

  • 12. Gamma heavy chain disease in man: independent structural abnormalities and reduced transcription of a functionally rearranged lambda L-chain gene result in the absence of L-chains.
    Teng MH; Rosen S; Gorny MK; Alexander A; Buxbaum J
    Blood Cells Mol Dis; 2000 Jun; 26(3):177-85. PubMed ID: 10950937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two isoforms of human membrane-bound alpha Ig resulting from alternative mRNA splicing in the membrane segment.
    Yu LM; Peng C; Starnes SM; Liou RS; Chang TW
    J Immunol; 1990 Dec; 145(11):3932-6. PubMed ID: 2246519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genomic organization of the CD28 gene. Implications for the regulation of CD28 mRNA expression and heterogeneity.
    Lee KP; Taylor C; Petryniak B; Turka LA; June CH; Thompson CB
    J Immunol; 1990 Jul; 145(1):344-52. PubMed ID: 2162892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The murine complement receptor gene family. III. The genomic and transcriptional complexity of the Crry and Crry-ps genes.
    Paul MS; Aegerter M; Cepek K; Miller MD; Weis JH
    J Immunol; 1990 Mar; 144(5):1988-96. PubMed ID: 2307848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase II alpha messenger RNA and protein in human HL-60 leukemia cells selected for resistance to mitoxantrone.
    Harker WG; Slade DL; Parr RL; Holguin MH
    Cancer Res; 1995 Nov; 55(21):4962-71. PubMed ID: 7585537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hinge deletion allelic variant of porcine IgA results from a mutation at the splice acceptor site in the first C alpha intron.
    Brown WR; Kacskovics I; Amendt BA; Blackmore NB; Rothschild M; Shinde R; Butler JE
    J Immunol; 1995 Apr; 154(8):3836-42. PubMed ID: 7706723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene mutations and alternate RNA splicing result in truncated Ig L chains in human gamma H chain disease.
    Cogné M; Bakhshi A; Korsmeyer SJ; Guglielmi P
    J Immunol; 1988 Sep; 141(5):1738-44. PubMed ID: 3137264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rearrangement of immunoglobulin genes in alpha heavy chain disease: a criterion of monoclonality].
    Fakhfakh F; Ayadi H; Bouguerra A; Fourati R; Ben Ayed F; Tsapis A; Dellagi K
    Arch Inst Pasteur Tunis; 1991; 68(3-4):251-9. PubMed ID: 1824506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms.
    Lee PL; Gelbart T; West C; Halloran C; Beutler E
    Blood Cells Mol Dis; 1998 Jun; 24(2):199-215. PubMed ID: 9642100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.